The role of HLA-G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis

Bone Marrow Transplantation

Volumn 47, Issue 1, 2012, Pages 120-124

  Chiusolo, P ^a   Bellesi, S ^a   Piccirillo, N ^a   Giammarco, S ^a   Marietti, S ^a   De Ritis, D ^a   Metafuni, E ^a   Stignani, M ^b   Baricordi, O R ^b   Sica, S ^a   Leone, G ^a   Rizzo, R ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

allo SCT; GvHD; human leukocyte antigen G; MTX

Indexed keywords

HLA G ANTIGEN; METHOTREXATE;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLELE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CAUSE OF DEATH; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GENDER; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HEMATOLOGIC MALIGNANCY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IMMUNOLOGICAL TOLERANCE; INCIDENCE; LYMPHOPROLIFERATIVE DISEASE; MALE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; POST TRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN FUNCTION; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA-G ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INDEL MUTATION; LEUKEMIA, MYELOID, ACUTE; MALE; METHOTREXATE; MIDDLE AGED; POLYMORPHISM, GENETIC; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84855718510     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2011.40     Document Type: Article

References (19)

1. Rebmann V, Busemann A, Lindemann M, Grosse-Wilde H. Detection of HLA-G5 secreting cells. Hum Immunol 2003; 64: 1017-1024. (Pubitemid 37413709)
2. Kovats S, Main EK, Librach C, Stubblebine M, Fischer SJ, DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990; 248: 220-223. (Pubitemid 120031455)
3. LeRond S, Le Maoult J, Creput C, Menier C, Deschamps M, Le Friec G et al. Alloareactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients. Eur J Immunol 2004; 34: 649-660. (Pubitemid 39255912)
4. Le Maux A, Noel G, Birebent B, Grosset JM, Vu N, De Giubert S et al. Soluble human leucocyte antigen- G molecules in peripheral blood haematopoietic stem cell transplantation: a specific role to prevent acute graft-versushost disease and a link with regulatory T cells. Clin Exp Immunol 2008; 152: 50-56. (Pubitemid 351347550)
5. Carosella ED, Moreau P, Aractingi S, Rouas-Freiss N. HLA-G: a shield against inflammatory aggression. Trends Immunol 2001; 22: 553-555. (Pubitemid 33016401)
6. Megret F, Prehaud C, Lafage M, Moreau P, Rouas-Freiss N, Carosella ED et al. Modulation of HLA-G and HLA-E expression in human neuronal cells after rabies virus or herpes virus simplex type I infections. Hum Immunol 2007; 68: 294-302. (Pubitemid 46497524)
7. Rouas-Freiss N, Moreau P, Menier C, LeMoult J, Carosella ED. Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses. Semin Cancer Biol 2007; 17: 413-421. (Pubitemid 350064561)
8. Pistoia V, Morandi F, Wang X, Ferrone S. Soluble HLA-G: are they clinically relevant? Semin Cancer Biol 2007; 17: 469-479. (Pubitemid 350064562)
9. Qiu J, Terasaki PI, Miller J, Mizutani K, Cai J, Carosella ED. Soluble HLA-G expression and renal graft acceptance. Am J Transplant. 2006; 6: 2152-2156. (Pubitemid 44199549)
10. Luque J, Torres MI, Aumente MD, Marín J, García-Jurado G, González R et al. Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy. Hum Immunol 2006; 67: 257-263. (Pubitemid 44255786)
11. Lila N, Amrein C, Guillemain R, Chevalier P, Latmouille C, Fabiani JN et al. Human leucocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 2002; 105: 1949-1954. (Pubitemid 34437623)
12. Crispim JC, Duarte RA, Soares CP, Costa R, Silva JS, Mendes-Junior CT. Human leucocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection. Transpl Immunol 2008; 18: 361-367.
13. Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, Moreau P. The 14 bp deletion- insertion polymorphism in the 30 UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 2003; 64: 1005-1010. (Pubitemid 37413707)
14. Hviid TV, Hylenius S, Rorbye C, Nielsen LG. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003; 55: 63-79. (Pubitemid 36702743)
15. Hviid TV, Rizzo R, Christiansen OB, Melchiorri L, Lindhard A, Baricordi OR. HLA-G and IL-10 in plasma in relation to HLA-G genotype and polymorphisms. Immunogenetics 2004; 56: 135-141. (Pubitemid 38916317)
16. Rebmann V, van de Ven K, Passler M, Pfeiffer K, Krebs D, Grosse-Wilde H. Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue Antigens 2001; 57: 15-21. (Pubitemid 32151071)
17. La Nasa G, Littera R, Locatelli F, Lai S, Alba F, Caocci G et al. The human leucocyte antigen-G 14-basepair polymorphism correlates with graft-versus-host disease in unrelated bone marrow transplantation for thalassaemia. Br J Haematol 2007; 139: 284-288. (Pubitemid 47493086)
18. Rizzo R, Rubini M, Govoni M, Padovan M, Melchiorri L, Stignani M et al. HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis. Pharmacogenet Genomics 2006; 16: 615-623. (Pubitemid 44223073)
19. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825-828.